Accueil>>Signaling Pathways>> Stem Cell>> Wnt/β-catenin>>Carboxylesterase-IN-2

Carboxylesterase-IN-2

Catalog No.GC65165

La carboxylestérase-IN-2 (composé 4u) est un puissant inhibiteur de la carboxylestérase notum avec une IC50 inférieure ou égale À 10 nM. Notum est un régulateur négatif de la signalisation Wnt agissant par l'hydrolyse d'un ester de palmitoléoylate, nécessaire À l'activité Wnt. La carboxylestérase-IN-2 a le potentiel pour la recherche sur les maladies cancéreuses.

Products are for research use only. Not for human use. We do not sell to patients.

Carboxylesterase-IN-2 Chemical Structure

Cas No.: 2764748-88-9

Taille Prix Stock Qté
5mg
270,00 $US
En stock
10mg
432,00 $US
En stock
25mg
855,00 $US
En stock
50mg
1 305,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Carboxylesterase-IN-2 (compound 4u) is a potent inhibitor of Carboxylesterase Notum with an IC50 less than or equal to 10 nM. Notum is a negative regulator of Wnt signaling acting through the hydrolysis of a palmitoleoylate ester, which is required for Wnt activity. Carboxylesterase-IN-2 has the potential for the research of cancer disease[1].

[1]. Steadman D, et al. Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity. J Med Chem. 2022;65(1):562-578.

Avis

Review for Carboxylesterase-IN-2

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Carboxylesterase-IN-2

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.